Mushrooms Inc (MSRM)

[2times2]

MSRM: Update & Acquisitions...Unrestricted shares preserved at 4.8M
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market LeadersPress Release | 02/23/2023
ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.
MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.

GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.

CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."

With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.
Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.
We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.

MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.
It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.
We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.
From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.

Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).

Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.
Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.

Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.
For more information, email [e-mail] or visit www.mushroomsinc.com

04/20/2023 Quarterly Report for the period ended March31, 2023
03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure

Outstanding Shares 37,985,760 04/22/2023
Restricted 33,162,392 04/22/2023
Unrestricted 4,823,368 04/22/2023

update by CEO:
see twitter https://twitter.com/MushroomsInc

MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing.
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc

[2times2]

Outstanding Shares 37,985,760 04/12/2023
Restricted 33,162,392 04/12/2023
Unrestricted 4,823,368 04/12/2023

[2times2]

Outstanding Shares 36,397,686 03/19/2023
Restricted 31,574,318 03/19/2023
Unrestricted 4,823,368 03/19/2023

[2times2]

Annual Report out...Unrestricted preserved at 4.6M:

03/06/2023 Attorney Letter with Respect to Current Information - Shell Status Opinion MSRM
03/06/2023 Attorney Letter with Respect to Current Information - MSRM - Current Information Letter
03/06/2023 Annual Report - MSRM 2022 Annual Report
https://www.otcmarkets.com/stock/MSRM/disclosure

[Stepbro69]

Shell badge gone soon?

[2times2]

agreed

[gains4us]

CEO is serious PLUS updates regularly and preserves the SS while getting the company out of the starting blocks

[i_like_bb_stock]

thx

[2times2]

update by CEO:

see twitter https://twitter.com/MushroomsInc

[mikenelson01]

Nice to see are not selling off MSRM. Be nice to see another push next week.

[Zardiw]

#DDAmanda Chart on $MSRM:



Z

[Stepbro69]

I do not have private message,

Can I find you on twitter?

[Zardiw]

So what is the scamming company moving under the Umbrella here?

Z

[Stepbro69]

Agreed, this has a bright future . Especially being on the cusp of the shroom boom. It will be massive

[MallenNV]

Another UMBRELLA scam. Hers how it works

It allows scammers who don’t want to or can’t go public for what ever the reason. They latch onto a public vehicle and acquire free trading shares that promise to jump start the liquidity and price but when they pump and stock UP and sell off all the free shares they received (usually in a day or two or a few months), once sold they vanish and leave the company and CEO to deal with the diluted shares and eventually the huge drop in share price and then people ask the CEO what happened to the HOT news and plans.

Its the same as a pump and dump but the pump is from non company affiliates who told the CEO if they issue then shares they will put the alleged company under the public vehicles umbrella. What that means is a scammer who can’t go public can just form some new LLC (private company) that is not real but a simple website and they look like a giant company, start a PR pump and dump, send out the pumpers to chat rooms, sell off the free shares they got from the CEO with the promise it will make that public company a huge success.

UMBRELLA is just a way scammers can sell publicly traded shares and have clean hands and make as much money as they would being a public pump and dump only they are not the ones public yet they market that their plan is part of the public company.

Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders

CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella.

[2times2]

under new management and new direction since last year this company has not added 1 share to the OS....a few restricted shares, held by previous insiders/employees, were converted from restricted to unrestricted...can't call that dilution and is not in the hands of the current management :) TINY FLOAT, NO DILUTION, NO CHANGE IN OS

[Johnstown]

$MSRM .0263 news and dilution go hand in hand with this ticker, done nothing but sell shares continuously for the last 3 mos, not a ton, but every single day, will probably be RED when the day is done, 650k traded vs 10 day ave of 120k

[2times2]

saw that...great update, indeed - wouldn't call it merger, though...steady wins the race...btw OTCX and CDEL just backed off on L2 in terms of shares offered = we might see the real ask and break through these last few shares

[gains4us]

Seems like a bunch of folks are lurking, since today there are various tweets to MSRM incl reference to "merger" news

[Stepbro69]

If it drops I will add more

[i_like_bb_stock]

yep a bit over 4 million float

[Stepbro69]

I discovered this last week and was going to enter but didn’t get around to it, as I am a big mushroom advocate and I know where this sector is headed. I happily chased this morning. 4 million float? I’ll hold till it moves back to dollars

[gains4us]

Looking at the SS and chart this could be a run away train soon. I got a solid stack

[i_like_bb_stock]

agreed

[2times2]

The float is tiny, the management transparent and reliably staying current, no convertible loans are being taken out, the business concept fantastic...and that lovely name, indeed - broad application of mushroom products is the future in a variety of fields

[i_like_bb_stock]

moving on air Mushrooms will be the MJ and its very early you dont get a better name than Mushrooms Inc with a 4M float

[2times2]

Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders Press Release | 02/23/2023

ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.

Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field.

MSRM is targeting grants specific to their goals, working with pioneers, scientists, and universities, on a global scale to develop scientifically proven products that advance health of body, mind, and environment. They have multiple proposals that they are currently reviewing for their costs to bring to market, timelines, scalability, as well as their positive financial, environmental and health impact. These proposals include a patentable process for the development of mycelium-based building supplies, a patentable process for mushroom related cosmetic and anti-aging skin products, a superfood product not currently seen in the marketplace as well as several remediation projects with new product innovation as an end result. These proposals are being assessed while keeping the progress on an off-shore lab and scientists for an evolved patentable mycelium thread.

GROWTH STRATEGY
In order to offset research costs and time on the industrial development side we are establishing pillars of development outside of the industrial mushroom market through acquisitions and joint ventures. The business model is based on the amazing qualities of mycelium and its networking capabilities as well as its ability to benefit from the network its developing.

CEO Kimberly Carlson shared, "I have been fortunate to connect with amazing pioneers and innovators in differing areas of the Mushroom Market in the US and abroad. Three realities have been consistent with the people behind the businesses and their processes. One is that this business model can bring like-minded companies together in order to benefit and fruit from a shared network under the public umbrella. Secondly, there are natural and substantial cross-points between these companies to mutually benefit from each other while growing as a whole. And the third is that there is a desire for many of these businesses to unite their expertise to others and share from a unified gain. By combining the power of shared ideals and resources through joint ventures, we can move as larger more developed companies do, but without limiting quality and compassion for social and environmental governance."

With a focus on profitability and mutually beneficial cross points, MSRM is assessing partnerships with complimentary businesses which would strategically advance the Company's reach into related markets through joint ventures and M&A activity.

Establishing pillars of development outside of the industrial mushroom market allows for a broad scope of proven profitability and cross-sharing of resources.

We seek to enter partnerships in the Cultivation Market, which includes substrate, spawn production, and fruiting. Cultivation gives life to all market pillars to some degree. It feeds directly into the Mushroom Nutraceutical and Medicinal Psylocibin Market with the addition of extraction, quality testing, product development, and processing. The Medicinal Mushroom Market requires legalization and branches into wellness retreats, treatment certifications and clinics.

MSRM is also evaluating several companies involved in the Myco-Remediation Market which uses fungi to clean oil spills, heavy metals, plastics and other pollutants from soil, water, and the atmosphere. All of these markets relate to the industrial and health innovation that the Company is pursuing in differing aspects and creates a connecting point for acceleration, mutual benefit and market share.

It is the belief of MSRM that connecting these pillars of the mushroom market through joint ventures and acquisitions, while focusing their innovation efforts on the industrial side of the market, will garner cross benefits financially and accelerate timelines during the major research and development phases.

We are simultaneously creating a vertically integrated business model for the businesses involved by aligning strengths between the companies under the umbrella of MSRM.

From an investor perspective, we are creating an avenue for investors to support a larger portion of the mushroom market, establishing a broader financial base of support for and from the networked companies while allowing for a more elastic ability to pivot, expand and connect to new industry pathways as they surface.

Market Opportunity
Mushrooms, Inc. operates in the North American segment of the functional mushroom market in the mycelium material and mushroom supplement product types. According to various industrial research firms, the global functional mushroom market is projected to show a compounded annual growth rate of over 9% for the next five years (Industry Arc and Vantage Market Research). The North American edible mushroom market was worth 11.99 billion in 2023 and is growing at a compounded annual growth rate of 9.48%, forecast to reach 20.91 billion by 2028 (Market Data Forecast). The North American functional mushroom market held 33.8% of the global market in 2020 and is growing at a compounded annual growth rate of 7% (Industry Arc).

Overview
Mushrooms, Inc. is a developing-stage emerging consumer products platform focused on the manufacturing and marketing of highly differentiated mushroom-based materials and functional supplements. The core growth pillars of the Mushrooms, Inc. platform are currently based on developing functional mushroom technologies. As a result of growing consumer demand for innovative, sustainable, and carbon-neutral products, Mushrooms, Inc. plans to grow revenues by penetrating the multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology, as well as expanding our platform to include the creation of supplements based on the proven health benefits of mushrooms.

Mushrooms, Inc. seeks to drive the growth of the bourgeoning functional mushroom industry through product innovation and development. Our current core business activity is environmentally beneficial product innovation utilizing self-growing, fibrous, and natural composite materials with controlled physical properties that can be produced in large quantities. Our product technologies focus on mycelium, the main component of fungi. This emerging biotechnology is used in the creation of carbon neutral products for the building, textile, packaging, and health care industries, as well as in the creation of supplements based on the proven health benefits of mushrooms.

Currently, our research focuses primarily on the significant thermal stability of mycelium materials, a result of mycelium's unique degradation qualities that expand the potential fields of application for mushroom-based products. Mushrooms, Inc.'s long-term goal is to build a strong scalable and widely recognized brand that authentically focuses on sustainable mushroom ingredients and novel functionality stemming from innovative biotech and materials science.

For more information, email [e-mail] or visit www.mushroomsinc.com

[i_like_bb_stock]

news https://www.otcmarkets.com/stock/MSRM/news?id=390996

[2times2]

No brainer to invest in this technology:

[gains4us]

Helpful! Thanks

[Timing101]

Here you go
--
Lets see
--
$MSRM This is totally under the Radar and is REAL. Check the SS , they did file a Patent that is coming up , they do have the product and their Mgt Team actually knows what they are doing. Here you go .
https://otcmarkets.com/stock/MSRM/security
https://mushroomsinc.com/team-3
https://twitter.com/MushroomsInc

[2times2]

Again, look at business concept, tiny float, shares held by management, chart, filings...IMO news and updates are just a matter of time. Bottom is in IMO

[i_like_bb_stock]

dont know but its so cheap

[gains4us]

Updates coming as far as you are aware of?

[i_like_bb_stock]

The only ones selling are selling to chase something else requires patience but just the name will make it worth so much more

[2times2]

OS remained the same for months and months...not diluting...a few restricted went into the float - that's all - and not surprising while management ramps up the business...website updated...concept of use of mushrooms leads to endless possibilities

[2times2]

Market Cap 727,954 02/02/2023
Authorized Shares 400,000,000 02/01/2023
Outstanding Shares 36,397,686 02/01/2023
Restricted 32,125,947 02/01/2023
Unrestricted 4,271,739 02/01/2023

[i_like_bb_stock]

nope not diluting people bored getting out mushrooms.com will be worth something in them selves not a fast trade patience trade

[Johnstown]

MSRM .0186 New Low of the year, congrats diluting mgmt, you could have been a star, but instead you are scum, glad you are happy

[2times2]

MSRM SS:
Outstanding Shares 36,397,686 01/04/2023
Restricted 32,489,924 01/04/2023
Unrestricted 3,907,762 01/04/2023

[AveragePenny]

$MSRM Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM”

https://www.globenewswire.com/news-release/2022/11/29/2564035/0/en/Mushrooms-Inc-Announces-Name-and-Ticker-Symbol-Change-on-OTC-Markets-to-MSRM.html

ESTERO, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly Marijuana Strategic Ventures, Inc., is pleased to announce that, effective November 29, 2022, the Company’s ticker symbol on the OTC Markets has changed from “MSVI” to its new symbol, “MSRM” and has been announced to FINRA’s daily list. The Company’s name change, which became effective with Nevada Secretary of State on June 28, 2022, has now also been reflected on OTC Markets.

It is important to note that Mushrooms, Inc. is the first company trading on the US stock market focused on the industrial side of Mushrooms.

“We are excited to begin trading under our new name and symbol as we continue our work building shareholder value. Our initial interest was to use the ticker MYCO for its relation to the word Mycology which is the study of fungi. We believe the ticker MSRM represents our name better as it tends to say the word Mushroom,” said Kimberly Carlson, the Company’s CEO.

Updates: The Company is continuing the development of the new mycelium derived textile through partnerships with University level educational institutions and building their team of consultants with a focus on mycology, chemistry and textile innovation.

The Company’s acquisition plan now involves the creation of an incubator and accelerator for start-ups focused on mycelium and mushroom based technologies that will feed into biotechnology,

New Website: We have created an updated website, at mushroomsinc.com, to represent our industrial focus. We are continuing to build out the pages of the new site which will include an investors page for updates and relative information, as well as an Alliances page to showcase the joint ventures and partnerships we are creating within the industry.

No action is required by current shareholders in relation to the ticker symbol change to MSRM

[2times2]

New Ticker; unchanged SS; Updates:

Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM”
Estero, FL, November 29, 2022 – Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly Marijuana Strategic Ventures, Inc., is pleased to announce that, effective November 29, 2022, the Company’s ticker symbol on the OTC Markets has changed from “MSVI” to its new symbol, “MSRM” and has been announced to FINRA’s daily list. The Company’s name change, which became effective with Nevada Secretary of State on June 28, 2022, has now also been reflected on OTC Markets. 
It is important to note that Mushrooms, Inc. is the first company trading on the US stock market focused on the industrial side of Mushrooms.

“We are excited to begin trading under our new name and symbol as we continue our work building shareholder value. Our initial interest was to use the ticker MYCO for its relation to the word Mycology which is the study of fungi. We believe the ticker MSRM represents our name better as it tends to say the word Mushroom,” said Kimberly Carlson, the Company’s CEO.
Update: The Company is continuing the development of the new mycelium derived textile through partnerships with University level educational institutions and building their team of consultants with a focus on mycology, chemistry and textile innovation

The Company’s acquisition plan now involves the creation of an incubator and accelerator for start-ups focused on mycelium and mushroom based technologies that will feed into biotechnology.

New Website: We have created an updated website at, mushroomsinc.com, to represent our industrial focus. We are continuing to build out the pages of the new site which will include an investors page for updates and relative information, as well as an Alliances page to showcase the joint ventures and partnerships we are creating within the industry. https://www.mushroomsinc.com/

Tiny preserved SS (float 3M):
Authorized Shares 400,000,000 11/28/2022
Outstanding Shares 36,397,686 11/28/2022
Restricted 33,449,924 11/28/2022
Unrestricted 2,947,762 11/28/2022
https://www.otcmarkets.com/stock/MSRM/security

recent Updates:
In The Media:
We have garnered media attention with the filing of the provisional patent with some links below:
https://www.ecotextile.com/2022082429755/materials-production-news/mycelium-innovator-files-for-patent.html

https://www.benzinga.com/pressreleases/22/08/g28598932/marijuana-strategic-ventures-inc-otc-msvi-now-mushrooms-inc-announces-filing-of-provisional-patent

https://www.theglobeandmail.com/investing/markets/stocks/MSVI/pressreleases/9171363/marijuana-strategic-ventures-inc-otc-msvi-announces-updates-for-mushrooms-inc-health-product-production-provisional-patent-and-business-plan-development/

https://www.yahoo.com/now/marijuana-strategic-ventures-inc-otc-123000305.html

https://www.textileworld.com/textile-world/fiber-world/2022/08/marijuana-strategic-ventures-inc-now-mushrooms-inc-announces-filing-of-provisional-patent-for-novel-mycelium-thread/
Myco Technology with Mushroom Textile Applications

https://www.tevonews.com/fibres-yarns-news/3233-mycelium-innovator-files-for-patent

https://darik.news/nevada/msvi-now-mushrooms-inc-announces-provisional-patent-filing-for-novel-mycelium-thread/648803.html

https://6park.news/nevada/msvi-now-mushrooms-inc-announces-the-filing-of-a-provisional-patent-for-a-new-mycelium-thread.html

https://startuplist.africa/startup/mycelium

https://topnewsguide.com/2022/08/24/marijuana-strategic-ventures-inc-otcmktsmsvi-stock-gains-on-filing-of-provisional-patent/

https://www.wallstreet-online.de/nachricht/15850263-marijuana-strategic-ventures-inc-otc-msvi-now-mushrooms-inc-announces-filing-of-provisional-patent-for-novel-mycelium-thread

[i_like_bb_stock]

$MSVI MARIJUANA STRATEGIC VENTURES INC is now $MSRM Mushrooms, Inc.

[JJZander]

New symbol MSRM

[Renee]

Marijuana Strategic Ventures Inc., MSVI, changed to Mushrooms Inc., MSRM:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[HoldEm777]

WEN

[Johnstown]

MSVI .026 LOY only down from $1.90 HOY, lol, what a bunch of diluting pigs, oh yea we got shrooms, lol ,more like shares to dump, losers in charge of a pipe dream, all they have done is dump shares, no real business here at all

[2times2]

OS tiny 36M, still...I'm adding for sure 10k at a time...love the business concept (see below)...I agree anything can happen incl. a $1 pps...best case scenario 100x - likely scenario 10x spikes - worst case hovering around a penny or two....lovin' it :)
Unrestricted 2,947,762 11/02/2022
Restricted 33,449,924 11/02/2022
Outstanding Shares 36,397,686 11/02/2022
Market Cap Market Cap 1,091,931 11/02/2022
Authorized Shares 400,000,000 11/02/2022

Mushrooms Inc. (MSVI), Announces Positioning for Global Acquisitions and Shareholder ESTERO, Fla., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Marijuana Strategic Ventures, Inc. (the “Company”)(OTC: MSVI) now Mushrooms Inc., Announces Positioning for Global Acquisitions and Shareholder Update.

Direction: The Company is pleased to announce that the resources that were allocated for the development and sales of Telogenix, a company developing nutraceutical mushroom products, has been re-allocated to the development of the Company’s own proprietary provisional patent technology and mushroom related business acquisitions.

Acquisitions: The Company is in the final stages of setting up a Dublin, Ireland office to head the acquisition of mushroom related business in the EU. This office is headed by Andrii Bruznia, who is a Ukrainian refugee with an extensive leadership background in global marketing and growth. Andrii delivered project management and business consulting services to scale 100+ projects for international clients such as HubSpot, Deluxe Marketing Solutions, Virgin, General Electric, Peace Corps, Franklin Covey, Oxford University Press, Harvard University, Vodafone, H&M, Marriott, National Geographic, Starbucks, Disney, Walmart and Victoria’s Secret. Working with clients from over 40 countries, Andrii has proven his ability in start-up launches, life cycle management, and has proven outcomes using Earned Media and Paid Media. His achievements include consultation services to the Head of the Ukrainian Business Support Center to win $4M Peace Corps grant to develop the economy of Ukraine, winner of 10 educational, economic, scientific and business development awards for the development of the Ukrainian financial system and growth of the economy. He was selected by the Ukrainian Executive Committee as official interpreter in negotiations between former US Ambassador to Ukraine (Carlos Pascual) and the Mayor of Mykolaiv (Vladimir Chajka). His lists of experience and achievements continues, and Mushrooms Inc. is proud to have him on the team. Andrii graduated with his MBA from the Wisconsin International University, with his MA in Finance and BA in Economics from European University of Finance, Management and Business.

Andrii Bruznia, Director of Acquisitions says, “I am looking forward to this new chapter in my life and the life of my family, as I join the Mushrooms Inc. team. This position will allow me to implement my skills in business and communication to unite Mushroom related companies with an opportunity for growth. I have spent a majority of time understanding the success and expansion potential of companies on both large and small scales and implementing solid pathways to financial gain. Because of this, I believe I am able to assess the acquisition value for both Mushrooms Inc. and the potential acquisition companies, bringing forth a mutually beneficial union.”

Innovation: We have focused our US resources on the prototype development of our textile innovation. Crossing borders to better understand and develop this new product is enabling for a broader perspective, privacy of formulation and is adding years of technological research to the team. We look forward to sharing the progress and ask for the patience of our shareholders in updates due to the nature of the work with its patent potential.

Kimberly Carlson, CEO, stated, “Working with mycelium to grow replacements for plastic and textiles is an amazing opportunity for Mushrooms Inc. to join a market with significant growth potential in its early stages, to be the first publicly traded company in the industrial mushroom market in the US, and to allow early supporters of regenerative agriculture to grow with us as investors.”

Name and Ticker Change: The Company is still in the process of the name and ticker change with FINRA. We are awaiting approval now.

In The Media:
We have garnered media attention with the filing of the provisional patent with some links below:
https://www.ecotextile.com/2022082429755/materials-production-news/mycelium-innovator-files-for-patent.html

https://www.benzinga.com/pressreleases/22/08/g28598932/marijuana-strategic-ventures-inc-otc-msvi-now-mushrooms-inc-announces-filing-of-provisional-patent

https://www.theglobeandmail.com/investing/markets/stocks/MSVI/pressreleases/9171363/marijuana-strategic-ventures-inc-otc-msvi-announces-updates-for-mushrooms-inc-health-product-production-provisional-patent-and-business-plan-development/

https://www.yahoo.com/now/marijuana-strategic-ventures-inc-otc-123000305.html

https://www.textileworld.com/textile-world/fiber-world/2022/08/marijuana-strategic-ventures-inc-now-mushrooms-inc-announces-filing-of-provisional-patent-for-novel-mycelium-thread/
Myco Technology with Mushroom Textile Applications

https://www.tevonews.com/fibres-yarns-news/3233-mycelium-innovator-files-for-patent

https://darik.news/nevada/msvi-now-mushrooms-inc-announces-provisional-patent-filing-for-novel-mycelium-thread/648803.html

https://6park.news/nevada/msvi-now-mushrooms-inc-announces-the-filing-of-a-provisional-patent-for-a-new-mycelium-thread.html

https://startuplist.africa/startup/mycelium

https://topnewsguide.com/2022/08/24/marijuana-strategic-ventures-inc-otcmktsmsvi-stock-gains-on-filing-of-provisional-patent/

https://www.wallstreet-online.de/nachricht/15850263-marijuana-strategic-ventures-inc-otc-msvi-now-mushrooms-inc-announces-filing-of-provisional-patent-for-novel-mycelium-thread

https://www.cnbc.com/quotes/MSVI

About Mushrooms Inc. (MSVI)

New Venture - Mushroom Technology Development

On June 28, 2022 Marijuana Strategic Ventures filed a name change to Mushrooms Inc. with the Nevada Secretary of State, to reflect the Company’s new business direction towards the mushroom industry. The Company is currently processing the official name and ticker symbol change corporate actions with FINRA while our newly amplified management team implements our industrial mushroom market and mushroom related business acquisition plan.

Mushrooms, Inc. is a publicly traded company on the OTC Markets with the stock symbol MSVI. We anticipate that the new ticker symbol for its Common Stock will be MYCO. We chose the trading symbol MYCO which is a prefix that denotes a relationship to fungus. From the Greek “mykes”, meaning fungus.

The vision for Mushrooms, Inc. is to support the growth of the mushroom industry through collaboration, innovation and development. Creating and supporting environmentally beneficial product innovation is at the heart of Mushrooms, Inc. Our current focus is on the industrial application of Mycelium for the creation of carbon neutral products for the building and health care industries. Research and Development is the path to achieving great innovation and the pioneers are the ones we look to for their fortitude and enduring dedication to the world of mycology. The working relationships we foster will result in scientifically proven products that advance health of body, mind and environment.

For more information, email [e-mail] or visit www.mushroomsinc.com

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

[Johnstown]

MSVI .0262 just one stinky smelly scummy, diluting Mushroom ticker, new LOY, with a very low float and idiots in mgmt, who are dumping this ticker down, total morons

[i_like_bb_stock]

agreeed